Markey Research Seminar
Distinguished Visitor Seminar Series

Friday, November 13, 2009
Noon - 12:50P
W.T. Young Library Auditorium

"Hematopoietic Stem Cell Aging:
Mechanism and Consequence"

Derrick J. Rossi, Ph.D.
Assistant Professor
Department of Pathology
Harvard Stem Cell Institute
Harvard Medical School
Boston, MA

Please spread the word by posting this flyer. 

Markey Research Seminar
Visiting Scholar

Friday, November 20, 2009
Noon - 12:50P
MN 263 Willard Medical Education Building

"Translational Pancreatic Cancer Research"

Keping Xie, M.D., Ph.D.
Associate Professor
M.D. Anderson Cancer Center
Houston, TX

Please spread the word by posting this flyer. 

Molecular and Biomedical
Pharmacology Seminar

Thursday, November 12, 2009
3 - 4P
MN 263 Willard Medical Education Building

"Neurobiological Mechanisms of Aging and Cognitive Flexibility"

James R. Moyer, Jr., Ph.D.
Associate Professor
Department of Psychology
University of Wisconsin-Milwaukee

Center for Oral Health Research
College of Dentistry / Internal Medicine
Grand Rounds

Monday, November 23, 2009
Noon - 1P
127 CTW (Commons Room)

"Assessing Recent Advancements in the Management of ITP
and Thrombocytopenia Secondary to Other Disorders"

Mitchell Shiffman, M.D.
Professor of Medicine,
Chief, Hepatology Section
Medical Director of the Liver Transplant Program
Virginia Commonwealth University Medical Center
Richmond, VA

This is a free CME Conference.  Those who pre-register, dlsatt00@email.uky.edu or 323-0887, will be provided with a Panera Bread box for lunch.  CME is sponsored by the France Foundation, ACCME-accredited CME Company, CE (UKCD)

Department of Health and Human Services RFA
NCI

"Innovative Technology Development for Cancer Research (R21)"

Department of Health and Human Services RFA
NCI

"Application and Early Stage Development of Emerging Technologies in Cancer Research (R21)"

Department of Health and Human Services RFA
NIH, NCI

"Validation and Advanced Development of Emerging Technologies for Cancer Research (R33)"

DoD Breast Cancer Postdoctoral
Fellowship Award

Closing Date:  December 2, 2009

Agency
Dept. of the Army -- USAMRAA

Description
The BCRP Postdoctoral Award mechanism was first offered in FY93. Since that time, 1,821 Postdoctoral (including Fellowship and Traineeship) Award proposals have been received, and 550 have been recommended for funding. The FY09 Postdoctoral Fellowship Award supports exceptionally talented recent medical or other doctoral graduates in their pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. Candidates for this award should exhibit a strong desire to pursue a career in breast cancer research. Under this award mechanism, the postdoctoral trainee is considered the Principal Investigator (PI) and, as such, should write the project narrative with appropriate direction from the mentor. While the PI is not required to have previous experience in breast cancer research, this application must focus on breast cancer research. Applications must provide evidence of the PI’s potential for success in becoming an independent breast cancer researcher based on his/her qualifications, characteristics, achievements, and letters of recommendations. The mentor (or co-mentor, if applicable) must possess the appropriate expertise and experience in breast cancer, to include peer reviewed breast cancer funding and publications, and clearly demonstrate a commitment to guiding the PI’s research and training. The application should include information about the mentor’s experience in conducting innovative research and how he/she intends to support the PI’s innovative breast cancer research endeavors. If the mentor is not an experienced breast cancer researcher, then a formal co-mentorship by an established breast cancer researcher is required. Applications must provide details on the suitability of the PI’s overall training plan and research project for attaining the goals of this mechanism. In addition, applications must elaborate on the training environment in which the candidate will work and how it will facilitate the candidate’s career development as an independent breast cancer researcher. Applications with a multidisciplinary research approach to breast cancer are highly encouraged but not required.

Announcement Number
W81XWH-09-BCRP-POSTDOC2

Contact Information
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Help Desk

DoD Breast Cancer Era of Hope
Scholar Award

Closing Date:  December 2, 2009

Agency
Dept. of the Army -- USAMRAA

Description
The BCRP Era of Hope Scholar Award mechanism was first offered in FY04. Since that time, 133 Era of Hope Scholar Award proposals have been received and 27 have been recommended for funding. The Era of Hope Scholar Award supports individuals who have high potential for innovation in breast cancer research early in their careers. Nominees for this award should be exceptionally talented, early-career scientists who have demonstrated that they are the “best and brightest” in their field(s) through extraordinary creativity, vision, and productivity. They also should exhibit strong potential for leadership in the breast cancer research community and be able to articulate a vision for the eradication of breast cancer. These individuals should challenge current dogma and demonstrate an ability to look beyond tradition and convention. The Era of Hope Scholar Award application must focus on the Principal Investigator’s (PI) record of creative and original accomplishments, potential for leadership in the breast cancer research community, and vision for eradicating breast cancer. These aspects of the application will receive greater emphasis in the review process than the proposed research project, although the proposed research project also will be considered. Experience in breast cancer research is not required; however, the application should focus on breast cancer research, and the PI must commit at least 50% of his/her full-time professional effort during the award period to breast cancer research.

Announcement Number
W81XWH-09-BCRP-EOHS2

Contact Information

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Help Desk

Matching Grants

Deadline:  Continuous

Sponsor: American Institute for Cancer Research (AICR), Research Department

http://fundingopps.cos.com/alerts/12132

Numerous funding opportunities from diverse sources are brought to the attention of the cancer center on a daily, weekly, or monthly basis. Notices of these opportunities are compiled at: http://markey.uky.edu/newsletter/funding.aspx .

Chen L, Swartz KR, Toborek M. Vessel Microport Technique for Applications in Cerebrovascular Research. Journal of Neuroscience Research 87(7): 1718-1727, 2009.

Li FX, Liu J, Park ES, Jo M, Curry TE. The B Cell Translocation Gene (BTG) Family in the Rat Ovary: Hormonal Induction, Regulation, and Impact on Cell Cycle Kinetics. Endocrinology 150(8): 3894-3902, 2009.

Ren Y, Zhang LP, Lu Y, Yang H, Westlund KN. Central Lateral Thalamic Neurons Receive Noxious Visceral Mechanical and Chemical Input in Rats. Journal of Neurophysiology 102(1): 244-258, 2009.